Web Analytics
RGEN (NASDAQ) 株価分析 | REPLIGEN CORPORATION – Deepscope
MARKET

Select Market Data Region

RGEN — REPLIGEN CORPORATION (Healthcare >> Medical Instruments & Supplies)

RGEN FAQ

What is RGEN's P/E ratio?

REPLIGEN CORPORATION (RGEN) currently trades at a P/E ratio of 132.94.

What is RGEN's ROE?

REPLIGEN CORPORATION reports a Return on Equity (ROE) of 2.44%.

What is RGEN's dividend yield?

REPLIGEN CORPORATION offers a dividend yield of 0.00%.

What is RGEN's Deepscope Quality Score?

Deepscope rates RGEN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RGEN?

Deepscope's AI Timing Score for RGEN is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RGEN belong to?

REPLIGEN CORPORATION is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

RGEN

REPLIGEN CORPORATION
USD 121.73
0.60 (0.50%) Day Change
132.94
P/E
0.27
D/E
2.4%
ROE
1.8%
ROA
0.00%
Div Yield
-0.75
PEG
USD 121.73
Price
0.60 (0.50%)
Day Change
NEWS SCORE: 98

RGEN, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Deepscope 分析 44%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
2970
  Magic Formula Rank by ROE
2970
  Magic Formula Rank by ROIC
2966
  Price 121.73
  PBV / Sector
3.25 / 4.59
  Earning Per Share 0.92
  PE / Sector
132.94 / 36.68
  PEG or PE/Growth / Sector
-0.75 / -1.22
  Average 1M Daily Value
142.01 M
GREAT
  Average 1W Daily Value
105.25 M
GREAT
Timing Factors 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
6.73 / 89.21
  NPM Average (%) / Sector
7.81 / 31.62
  NPM Change Average (%) / Sector
-124.19 / 221.46
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
1.75 / 8.71
  ROA Average (%) / Sector
2.27 / -23.75
  ROA Change Average (%) / Sector
-129.81 / 110.99
  ROE (%) / Sector
2.44 / 11.02
  ROE Average (%) / Sector
3.06 / 425.31
  ROE Change Average (%) / Sector
-128.50 / 113.27
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 1.11
  Dividend Average (%) / Sector
N/A / 1.44
  Dividend Change Average (%) / Sector
N/A / 14.94
登録情報
X
  Analyze Date 2026-06-04 09:23:58
  Symbol RGEN
  Name REPLIGEN CORPORATION
  Sector Healthcare >> Medical Instruments & Supplies
  Market NASDAQ
  Listed Shares 56.41 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 6,832.67 / 15,691.23
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: Building 1, Waltham, MA, United States, 02453

Phone: 781 250 0111

Website: https://www.repligen.com

Employees: 2,000

Sector: Healthcare >> Medical Instruments & Supplies

Description: Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

ME vs SECTOR Healthcare >> Medical Instruments & Supplies

RGEN (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
RGEN
RGEN
USD 121.73 (0.50%)
+ Watch + Port Chart